Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

AMD vs MTNB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AMD Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 9–1 Matrix Metrics)

AMD Overall Winner 6-Pillar Tally: AMD 6 – 0 MTNB Matrix Metrics: AMD 9 – 1 MTNB

As of Nov 19, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over Matinas BioPharma Holdings, Inc. (MTNB) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMD carries a Unified Composite Score of 47.5/100 (HOLD) at $489.19 (27.3x Forward P/E, 17.8% operating margin), whereas MTNB carries 54.6/100 (HOLD) at $0.81 (N/M Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While MTNB currently prints a higher short-term Unified Composite Score (54.6/100 HOLD vs. AMD 47.5/100 HOLD), AMD captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (17.8% vs. 0.0% operating margin) and revenue trajectory (+44.7% vs. -100.0% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMD vs MTNB
AMD NASDAQ Head-to-Head Winner
Advanced Micro Devices
Semiconductors & Related Devices
$489.19
-7.72% 1D
Market Cap $877.4B
TTM Revenue $45.4B
Forward P/E 27.3x
Beta / 30D Vol 3.61β · 120% Vol
Unified Composite Score
47.5 / 100 HOLD
Tech 19.0 Fund 38.0 Flow 58.0 Mom 44.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.2 · SMA20: $513.70 · SMA50: $554.93
MTNB NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap $979,904
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -7.20β · 147% Vol
Unified Composite Score
54.6 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 33
RSI-14: 33.0 · SMA20: $1.26 · SMA50: $1.47

6-Pillar Scorecard Institutional Category Breakdown (AMD 6 – 0 MTNB)

Columns: Metric · AMD · MTNB
1. Valuation Multiples AMD
Forward P/E 27.3x N/M
Trailing P/E 113.3x N/M
PEG Ratio 0.45x N/M
EV / Revenue 19.3x N/M
2. Growth & Scale AMD
Revenue Growth (YoY) +44.7% -100.0%
Earnings Growth (YoY) +93.8% +0.0%
TTM Revenue (USD) $45.4B N/A
Market Cap $877.4B $979,904
3. Profitability & Quality AMD
Gross Margin 56.0% N/A
Operating Margin 17.8% 0.0%
Net Profit Margin 16.8% 0.0%
Return on Equity (ROE) 12.0% -147.5%
4. Balance Sheet & Cash Flow AMD
Cash Generation (TTM) $7.06B N/A
Cash Flow Margin 15.5% N/A
Net Cash / Leverage $1.51B Net Debt (0.13x D/E) $1.2M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AMD
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 128.2% (17th %ile) N/A (N/A)
Put/Call OI Skew 1.08x (Balanced) N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat AMD
OpEx & R&D Intensity 38.2% of Rev ($17.4B) N/A
90D R&D Disclosures 7 papers 0 papers
Competitive Moat Concentrated Oligopoly Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role AI Accelerator & Server Chiplet Designer Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMD (9) vs MTNB (1)
Institutional Metric AMD MTNB Criterion Row Edge
Market Capitalization
Scale
$877.4B $979,904 Larger Scale AMD
Trailing P/E Ratio
Valuation
113.3x N/M Lower Multiple AMD
Forward P/E Ratio
Valuation
27.3x N/M Lower Multiple AMD
Revenue Growth (YoY)
Growth
+44.7% -100.0% Higher Growth AMD
Operating Margin (TTM)
Profitability
17.8% 0.0% Higher Margin AMD
Net Profit Margin
Profitability
16.8% 0.0% Higher Margin AMD
Return on Equity (ROE)
Capital Efficiency
12.0% -147.5% Higher ROE AMD
52-Week Range Position
Momentum
64% ($188–$659) 22% ($0–$3) Stronger Trend AMD
Beta / 30D Volatility
Risk Regime
3.61β · 120% Vol -7.20β · 147% Vol Lower Realized Risk AMD
Unified Institutional Score
Composite Signal
47.5 / 100 (HOLD) 54.6 / 100 (HOLD) Higher Composite MTNB
Trailing 12M Revenue (USD)
Operating Scale
$45.4B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
56.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.45x PEG · 19.3x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$7.06B ($1.51B Net Debt (0.13x D/E)) N/A ($1.2M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AMD +35.21 pp
AMD: -11.49% · MTNB: -46.7%
3M Horizon MTNB +304.12 pp
AMD: +3.37% · MTNB: +307.49%
6M Horizon MTNB +12.12 pp
AMD: +8.81% · MTNB: +20.93%
1Y Horizon AMD +143.77 pp
AMD: +112.42% · MTNB: -31.35%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period AMD Revenue MTNB Revenue AMD Op. Margin MTNB Op. Margin Margin Leader
FY2018 $6.47B $0M 7.0% -12230.9% AMD
FY2019 $6.73B $0M 9.4% -21067.4% AMD
FY2020 $9.76B $0M 14.0% -15288.4% AMD
FY2021 $16.4B $0M 22.2% -74954.5% AMD
FY2022 $23.6B $0M 5.4% -771.3% AMD
FY2023 $22.7B $0M 1.8% -2168.4% AMD
FY2024 $25.8B N/A 7.4% N/A AMD
FY2025 $34.6B N/A 10.7% N/A AMD

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMD CONSOLIDATION
106d in phase · OBV NEUTRAL
Current IV 128.2%
IV Percentile 17th %ile
Put/Call OI Skew 1.08x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor $450.00
Call Wall Magnet $500.00
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Put Floor: $450.00 (-8.0%) Spot: $489.19 Call Magnet: $500.00 (+2.2%)
  • Extended consolidation (106 days)
  • IV expanding (+13.5%) but put wall rising - pre-earnings positioning (neutral)
  • Put wall rising (+$50) - support strengthening
MTNB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MTNB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $504.28 · IV 73.5%

AMD Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($50,428)

Compare $50,428 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 73.5% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $510 / $580 Bull Call Spread

Buy 1x $510C · Sell 1x $580C · 31d

Net Entry $2,436 Debit
T+5d @ +5% Move +$583 (+24%)
Max Risk / Buffer $2,436 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $440 / $410 Bull Put Spread

Sell 1x $440P · Buy 1x $410P · 31d

Net Entry $731 Credit
Max Credit / Yield +$731 (+32.2% RoM)
Max Risk / Buffer -14.2% Cushion ($2,269 Mgn)
5d Edge & Liquidity 76% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq A

Dec 18 $450P / $520-$590C Seagull

Sell 1x $450P · Buy 1x $520/$590C · 31d

Net Entry $52 Debit
T+5d @ +5% Move +$1,463 (+21.3% RoM)
Max Risk / Buffer -10.8% Put Cushion ($6,861 Mgn)
5d Edge & Liquidity 1.0x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMD Moat Profile Concentrated Oligopoly Moat
AI Accelerator & Server Chiplet Designer
Data center GPU accelerators and server CPU chiplets scale directly with upstream leading-edge foundry utilization and cloud server integration.
OpEx & R&D Reinvestment 38.2% of Rev ($17.4B)
90D Engineering Disclosures 7 Published · LLM Efficiency / Architecture
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries Samsung Electronics ASE Technology Holding
Active 90D Technical Topics:
Edge AI / Inference Chips Hardware-Agnostic ML Compilers Inference Serving / Speculative Decoding KV-Cache / Attention Memory Compression Mixture-of-Experts / Sparse Models
MTNB Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $979,904 market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AMD vs MTNB Key Questions & Quantitative Answers

As of Nov 19, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over Matinas BioPharma Holdings, Inc. (MTNB) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMD carries a Unified Composite Score of 47.5/100 (HOLD) at $489.19 (27.3x Forward P/E, 17.8% operating margin), whereas MTNB carries 54.6/100 (HOLD) at $0.81 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While MTNB currently prints a higher short-term Unified Composite Score (54.6/100 HOLD vs. AMD 47.5/100 HOLD), AMD captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (17.8% vs. 0.0% operating margin) and revenue trajectory (+44.7% vs. -100.0% YoY).

AMD leads the Growth & Scale pillar: AMD posts +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin), compared with MTNB at -100.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), AMD cumulative revenue shifted +435.4% while MTNB shifted N/A. In operating R&D and SG&A reinvestment, AMD deploys 38.2% of Rev ($17.4B) (7 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MTNB.

AMD screens cheaper on headline valuation multiples. AMD trades at 27.3x Forward P/E, 113.3x Trailing P/E, 0.45x PEG, and 19.3x EV/Revenue (15.5% FCF margin), whereas MTNB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMD (12.0% ROE) versus MTNB (-147.5% ROE) capital efficiency.

In options market volatility and institutional positioning, AMD carries 128.2% implied volatility (17th %ile, Compressed (<25th %ile)), a 1.08x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (3.61β · 120% Vol realized risk). By comparison, MTNB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-7.20β · 147% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.